logo

For the Inventor, By the Inventor

Los Angeles, CA, United States of America

Abraxis Bioscience, LLC


USPTO Granted Patents = 82

% Expired Patents = 7.3



Trademarks = 13

Forward Citations = 2,598

Loading Chart...
Loading Chart...

29 inventors (with patents filed for the assignee):

goldMedal Neil P Desai (71 out of 142 patents)

silverMedal Patrick Soon-Shiong (45 out of 475 patents)

bronzeMedal Vuong Trieu (27 out of 35 patents)

4.  Willard Foss (8 out of 8 patents)

5.  Chunlin Tao (8 out of 32 patents)

6.  Viktor Peykov (7 out of 7 patents)

7.  Daniel W Pierce (5 out of 11 patents)

8.  Andrew Yang (5 out of 15 patents)

9.  Tapas De (5 out of 5 patents)

10.  Markus Renschler (4 out of 4 patents)

11.  Rajesh R Shinde (3 out of 14 patents)

12.  Kirk Patrick Seward (3 out of 43 patents)

13.  Zachary Yim (3 out of 3 patents)

14.  Cheng Zhi Yu (3 out of 3 patents)

15.  Qinwei Wang (2 out of 14 patents)


Core Competencies:
Nanoparticle
Therapeutics
Cancer Treatment
Drug Delivery
mTOR Inhibitors
Albumin
Pharmaceutical Compositions
Epithelioid Cell Tumors
Breast Cancer
Lung Cancer
Bladder Cancer
Hepatocellular Carcinoma

82 patents:

1. 12324860 - Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin (2025-06-10),
2. 12133844 - Methods of treating epithelioid cell tumors (2024-11-05),
3. 12061183 - Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug (2024-08-13),
4. 11944708 - Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin (2024-04-02),
5. 11497737 - Pharmaceutical compositions of albumin and rapamycin (2022-11-15),
6. 11320416 - Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug (2022-05-03),
7. 10973806 - Methods of treating epithelioid cell tumors comprising administering a composition comprising nanoparticles comprising an mTOR inhibitor and an albumin (2021-04-13),
8. 10900951 - Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel (2021-01-26),
9. 10744110 - Methods of treating lung cancer (2020-08-18),
10. 10705070 - Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug (2020-07-07),
11. 10682420 - Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane (2020-06-16),
12. 10660965 - Methods of enhancing drug delivery and effectiveness of therapeutic agents (2020-05-26),
13. 10555912 - Use of polymeric excipients for lyophilization or freezing of particles (2020-02-11),
14. 10527604 - Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel (2020-01-07),
15. 10413531 - Methods of treating bladder cancer (2019-09-17),
Abraxis BioScience, LLC is a leading science-based biopharmaceutical company focused on developing and commercializing innovative therapies for patients with challenging medical conditions. With a strong commitment to research and development, Abraxis specializes in the development of targeted therapeutics and delivery systems, including the proprietary nab® technology platform. The company's mission is to improve patients' lives by providing them with high-quality, effective, and safe treatments.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Abraxis Bioscience, LLC
82 Patents

#21 in Los Angeles, CA

#1,046 in California

#4,522 in US

#9,246 in the World

Los Angeles, CA (US)
Los Angeles, CA, United States of America

Abraxis Bioscience, LLC

Forward Citations = 2,598

29 inventors:

goldMedal Neil P Desai (71 out of 142 patents)

silverMedal Patrick Soon-Shiong (45 out of 475 patents)

bronzeMedal Vuong Trieu (27 out of 35 patents)

4.  Willard Foss (8 out of 8 patents)

5.  Chunlin Tao (8 out of 32 patents)

Please report any incorrect information to [email protected]
Loading…